Ruxolitinib for steroid-refractory graft versus host disease in pediatric HSCT: high response rate and manageable toxicity
Yasmina Mozo(Hospital Universitario La Paz), Beatriz Ruz-Caracuel(Hospital La Paz Institute for Health Research), Juan Manuel Torres(Hospital La Paz Institute for Health Research), David Bueno(Hospital Universitario La Paz), Alba Fernández‐Arroyo(Hospital Universitario La Paz), Cristina Ferreras(King's College London), Adela Escudero(Hospital Clínico San Carlos), Antonio Pérez‐Martínez(Hospital Universitario La Paz), Blanca Rosich(Hospital Universitario La Paz), María Luz Uria Oficialdegui(Vall d'Hebron Hospital Universitari), Cristina Díaz de Heredia(Universitat Autònoma de Barcelona), Luisa Sisinni(Hospital de Sant Pau), Laura Alonso(Vall d'Hebron Hospital Universitari), Carmen Mestre‐Durán(Hospital La Paz Institute for Health Research), Itsaso Losantos(Hospital Universitario La Paz), María Isabel Benítez‐Carabante
Cited by 28
Related Papers
B cell–helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen
|Nature Immunology|2011|724
Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel
|Haematologica|2014|389
Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study
|Journal of Clinical Oncology|2020|333
Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study
|Journal of Allergy and Clinical Immunology|2017|318